PHARMACIE ULUSOY: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
PHARMACIE ULUSOY
Largest movements
- Intangible fixed assets -€30,000
down €30,000 (-19.5%), from €154,098 to €124,098
- Current investments +€27,024
new in 2025: €27,024
- Tangible fixed assets -€18,767
down €18,767 (-6.4%), from €292,664 to €273,897
- Stocks and contracts +€16,861
up €16,861 (+11.7%), from €144,293 to €161,153
- Debts after one year -€61,098
down €61,098 (-18.4%), from €332,812 to €271,715
of which Financial debts: -€50,047
- Other debts +€52,243
up €52,243 (+629%), from €8,300 to €60,543
- Reserves +€16,078
up €16,078 (+8.2%), from €195,785 to €211,863
- Tax, wage and social debts -€8,934
down €8,934 (-20.9%), from €42,826 to €33,893
of which Taxes: -€12,882
- Gross operating margin +€53,619
up €53,619 (+23.5%), from €228,567 to €282,186
- Staff costs +€27,733
up €27,733 (+29.8%), from €93,009 to €120,742
- Taxes +€5,993
up €5,993 (+38.6%), from €15,539 to €21,532
- Depreciation -€5,630
down €5,630 (-9.3%), from €60,328 to €54,698
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €747,867 | €741,462 | -€6,405 | -0.9% |
| Fixed assets | 21/28 | €446,762 | €397,996 | -€48,767 | -10.9% |
| Intangible fixed assets | 21 | €154,098 | €124,098 | -€30,000 | -19.5% |
| Tangible fixed assets | 22/27 | €292,664 | €273,897 | -€18,767 | -6.4% |
| Land and buildings | 22 | €199,633 | €192,343 | -€7,290 | -3.7% |
| Plant, machinery and equipment | 23 | €51,382 | €49,247 | -€2,135 | -4.2% |
| Furniture and vehicles | 24 | €41,649 | €32,307 | -€9,341 | -22.4% |
| Current assets | 29/58 | €301,105 | €343,466 | +€42,362 | +14.1% |
| Stocks and contracts in progress | 3 | €144,293 | €161,153 | +€16,861 | +11.7% |
| Stocks | 30/36 | €144,293 | €161,153 | +€16,861 | +11.7% |
| Amounts receivable within one year | 40/41 | €98,245 | €98,736 | +€492 | +0.5% |
| Trade receivables | 40 | €91,536 | €98,036 | +€6,500 | +7.1% |
| Other amounts receivable | 41 | €6,709 | €700 | -€6,009 | -89.6% |
| Current investments | 50/53 | - | €27,024 | +€27,024 | |
| Cash at bank and in hand | 54/58 | €56,551 | €53,656 | -€2,894 | -5.1% |
| Deferred charges and accrued income | 490/1 | €2,017 | €2,897 | +€880 | +43.6% |
| Total equity and liabilities | 10/49 | €747,867 | €741,462 | -€6,405 | -0.9% |
| Equity | 10/15 | €215,785 | €231,863 | +€16,078 | +7.5% |
| Contributions | 10/11 | €20,000 | €20,000 | = | 0.0% |
| Reserves | 13 | €195,785 | €211,863 | +€16,078 | +8.2% |
| Distributable reserves | 133 | €195,785 | €211,863 | +€16,078 | +8.2% |
| Amounts payable | 17/49 | €532,082 | €509,599 | -€22,482 | -4.2% |
| Amounts payable after more than one year | 17 | €332,812 | €271,715 | -€61,098 | -18.4% |
| Financial debts | 170/4 | €321,761 | €271,715 | -€50,047 | -15.6% |
| Other amounts payable | 178/9 | €11,051 | - | -€11,051 | |
| Amounts payable within one year | 42/48 | €199,185 | €236,545 | +€37,359 | +18.8% |
| Current portion of amounts payable after more than one year | 42 | €49,344 | €50,047 | +€703 | +1.4% |
| Trade debts | 44 | €98,715 | €92,062 | -€6,653 | -6.7% |
| Suppliers | 440/4 | €98,715 | €92,062 | -€6,653 | -6.7% |
| Taxes, remuneration and social security | 45 | €42,826 | €33,893 | -€8,934 | -20.9% |
| Taxes | 450/3 | €27,647 | €14,765 | -€12,882 | -46.6% |
| Remuneration and social security | 454/9 | €15,179 | €19,127 | +€3,948 | +26.0% |
| Other amounts payable | 47/48 | €8,300 | €60,543 | +€52,243 | +629% |
| Accrued charges and deferred income | 492/3 | €84 | €1,340 | +€1,256 | +1,494% |
| Remuneration, social security and pensions | 62 | €93,009 | €120,742 | +€27,733 | +29.8% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €60,328 | €54,698 | -€5,630 | -9.3% |
| Other operating charges | 640/8 | €5,048 | €3,707 | -€1,341 | -26.6% |
| Non-recurring operating charges | 66A | €300 | - | -€300 | |
| Gross operating margin | 9900 | €228,567 | €282,186 | +€53,619 | +23.5% |
| Operating profit (loss) | 9901 | €69,882 | €103,039 | +€33,157 | +47.4% |
| Financial income | 75/76B | €198 | €193 | -€5 | -2.5% |
| Recurring financial income | 75 | €198 | €193 | -€5 | -2.5% |
| Financial charges | 65/66B | €6,322 | €5,623 | -€699 | -11.1% |
| Recurring financial charges | 65 | €6,322 | €5,623 | -€699 | -11.1% |
| Profit (loss) for the period before taxes | 9903 | €63,758 | €97,609 | +€33,851 | +53.1% |
| Income taxes | 67/77 | €15,539 | €21,532 | +€5,993 | +38.6% |
| Profit (loss) for the period | 9904 | €48,220 | €76,078 | +€27,858 | +57.8% |
| Profit (loss) for the period to be appropriated | 9905 | €48,220 | €76,078 | +€27,858 | +57.8% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 29 October 2026 via checked.be.